bevacizumab,panitumumab
amgen,roche,takeda
['bevacizumab', 'panitumumab', '#gi', 'crcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'beva']
#asco22 plenary presents difference in os in left sided subgroup ras wt #crcsm in panitumumab + mfolfox6 vs bevacizumab + mfolfox6. #gionc 
#FosterCare alum, #GIonc, #pallonc, and #survonc doc @ParkviewHealth.Uniting support and cancer care #supponc #hpm #hapc  Tweets are own.